Product approval process to be expedited
Published: 2006-12-07 06:59:00
Updated: 2006-12-07 06:59:00
The new product approval process, which has been delayed due to the recent generic drugs' bioequivalence test data fabrication, may be facilitated by a newly formed task force team, according to the Korea Food and Drug Administration.
In a meeting of people with the Korea Pharmaceuticals Manuf...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
